Table 3 Results and performances of the multivariable modeling involving the deep learning risk scores and the FNCLCC grade.
Predictors | HR | P value | c-index in Training | c-index in Validation-1 | c-index in Validation-2 | ||
|---|---|---|---|---|---|---|---|
DL-C model | |||||||
Size (mm) | 1.01 (1.01–1.02) | < 0.0001*** | 0.793 (0.732–0.854) | 0.759 (0.643–0.876) | 0.741 (0.662–0.821) | ||
Histologic type (ref: M/RC-LPS) | |||||||
Leiomyosarcoma | 1.66 (0.42–6.59) | 0.4679 | |||||
Liposarcoma | 0.26 (0.06–1.15) | 0.0760 | |||||
Myxofibrosarcoma | 0.56 (0.13–2.35) | 0.4298 | |||||
Other | 1.41 (0.39–5.11) | 0.5987 | |||||
Undifferentiated sarcoma | 0.54 (0.15–1.98) | 0.3547 | |||||
DL-C High risk | 3.28 (1.56–6.89) | 0.0018** | |||||
Age (years) | 1.03 (1–1.05) | 0.0416* | |||||
Chemotherapy (yes) | 0.63 (0.24–1.67) | 0.3583 | |||||
Radiotherapy (yes) | 0.57 (0.28–1.16) | 0.1201 | |||||
DL-P model | |||||||
Size (mm) | 1.02 (1.01–1.02) | < 0.0001*** | 0.851 (0.803–0.900) | 0.74 (0.635–0.845) | 0.667 (0.573–0.760) | ||
Histologic type (ref: M/RC-LPS) | |||||||
Leiomyosarcoma | 0.43 (0.09–2.05) | 0.2926 | |||||
Liposarcoma | 0.1 (0.02–0.5) | 0.0051* | |||||
Myxofibrosarcoma | 0.16 (0.03–0.8) | 0.0253* | |||||
Other | 0.52 (0.13–2.2) | 0.3769 | |||||
Undifferentiated sarcoma | 0.12 (0.03–0.54) | 0.0054* | |||||
DL-P High risk | 23.41 (6.98–78.5) | < 0.0001*** | |||||
Age (years) | 1.01 (0.99–1.04) | 0.2782 | |||||
Chemotherapy (yes) | 0.62 (0.23–1.67) | 0.3451 | |||||
Radiotherapy (yes) | 0.52 (0.26–1.04) | 0.0658 | |||||
DL-R model | |||||||
Size (mm) | 1.01 (1.01–1.02) | < 0.0001*** | 0.790 (0.733–0.847) | 0.690 (0.564–0.817) | 0.664 (0.567–0.760) | ||
Histologic type (ref: M/RC-LPS) | |||||||
Leiomyosarcoma | 2.6 (0.67–10.03) | 0.1656 | |||||
Liposarcoma | 0.46 (0.12–1.83) | 0.2695 | |||||
Myxofibrosarcoma | 1.19 (0.31–4.53) | 0.8036 | |||||
Other | 1.95 (0.56–6.81) | 0.2958 | |||||
Undifferentiated sarcoma | 0.92 (0.27–3.12) | 0.8904 | |||||
DL-R (binary) | 3.74 (1.76–7.96) | 0.0006*** | |||||
Age (years) | 1.02 (1–1.04) | 0.1094 | |||||
Chemotherapy (yes) | 1.01 (0.39–2.63) | 0.9865 | |||||
Radiotherapy (yes) | 0.46 (0.22–0.95) | 0.0347* | |||||
DL-CP model | |||||||
Size (mm) | 1.01 (1.01–1.02) | < 0.0001*** | 0.819 (0.761–0.877) | 0.74 (0.623–0.856) | 0.698 (0.604–0.791) | ||
Histologic type (ref: M/RC-LPS) | |||||||
Leiomyosarcoma | 0.57 (0.13–2.51) | 0.4605 | |||||
Liposarcoma | 0.22 (0.05–0.97) | 0.0458* | |||||
Myxofibrosarcoma | 0.26 (0.06–1.17) | 0.0793 | |||||
Other | 0.87 (0.23–3.26) | 0.8379 | |||||
Undifferentiated sarcoma | 0.22 (0.06–0.89) | 0.0342* | |||||
DL-CP High risk | 8.82 (3.39–22.96) | < 0.0001*** | |||||
Age (years) | 1.03 (1.01–1.06) | 0.0068* | |||||
Chemotherapy (yes) | 0.68 (0.25–1.8) | 0.4324 | |||||
Radiotherapy (yes) | 0.79 (0.38–1.64) | 0.5224 | |||||
DL-CPR model | |||||||
Size (mm) | 1.01 (1.01–1.02) | < 0.0001*** | 0.804 (0.738–0.870) | 0.786 (0.689–0.883) | 0.698 (0.620–0.775) | ||
Histologic type (ref: M/RC-LPS) | |||||||
Leiomyosarcoma | 1.76 (0.46–6.67) | 0.4082 | |||||
Liposarcoma | 0.55 (0.14–2.16) | 0.3927 | |||||
Myxofibrosarcoma | 0.69 (0.18–2.61) | 0.5808 | |||||
Other | 1.99 (0.56–7.06) | 0.2860 | |||||
Undifferentiated sarcoma | 0.58 (0.17–1.96) | 0.3809 | |||||
DL-CPR High risk | 6.86 (2.91–16.18) | < 0.0001*** | |||||
Age (years) | 1.02 (1–1.05) | 0.0693 | |||||
Chemotherapy (yes) | 0.79 (0.3–2.06) | 0.6271 | |||||
Radiotherapy (yes) | 0.54 (0.27–1.07) | 0.0758 | |||||
Grade-based model | |||||||
Size (mm) | 1.01 (1.01–1.02) | < 0.0001*** | 0.764 (0.699–0.828) | 0.739 (0.621–0.856) | 0.723 (0.652–0.794) | ||
Histologic type (ref: M/RC-LPS) | |||||||
Leiomyosarcoma | 2.61 (0.71–9.65) | 0.1493 | |||||
Liposarcoma | 0.4 (0.1–1.69) | 0.2136 | |||||
Myxofibrosarcoma | 1.09 (0.28–4.28) | 0.8981 | |||||
Other | 2.21 (0.66–7.44) | 0.2002 | |||||
Undifferentiated sarcoma | 0.86 (0.25–2.96) | 0.8093 | |||||
FNCLCC Grade (ref: grade I) | 1.87 (0.59–5.96) | 0.2908 | |||||
Age (years) | 1.02 (1–1.05) | 0.0444* | |||||
Chemotherapy (yes) | 0.71 (0.27–1.81) | 0.4697 | |||||
Radiotherapy (yes) | 0.61 (0.3–1.23) | 0.1689 | |||||